Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sueli Miyuki Yamauti"'
Autor:
Mariana Pereira da Soledade, Sueli Miyuki Yamauti, Andressa Simões Aguiar, Carolina Sucupira, Márcia Teresinha Lonardoni Crozatti
Publikováno v:
Cadernos de Saúde Pública, Vol 40, Iss 9 (2024)
A tuberculose (TB) é uma doença infectocontagiosa que ainda representa um grave problema de saúde pública no mundo. Na população pediátrica, os fatores que levam ao abandono do tratamento da TB, especialmente em regiões de elevada prevalênci
Externí odkaz:
https://doaj.org/article/8957c3518b37490f8569fcb696d084a2
Autor:
Sueli Miyuki Yamauti, Jorge Otávio Maia Barreto, Silvio Barberato-Filho, Fernanda Lacerda da Silva Machado, Luciane Cruz Lopes
Publikováno v:
Systematic Reviews, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract Background The judicialization of health care can be understood as a societal response to pressing healthcare needs, which probably are not being adequately addressed by the current healthcare system. This phenomenon increases the strain on
Externí odkaz:
https://doaj.org/article/2fbf91893f334ea3b82541896d9af161
Autor:
Rejane Coan Ferretti Mayer, Maíra Ramos Alves, Sueli Miyuki Yamauti, Marcus Tolentino Silva, Luciane Cruz Lopes
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
ContextPeople with mental disorders can acquire long-term disabilities, which could impair their functioning and quality of life (QoL), requiring permanent care and social support. Systematic data on QoL and functioning, which could support a better
Externí odkaz:
https://doaj.org/article/7be0ec1ade9e46a0859967df401dbd68
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundThe judicialization of health care is a social claim concerning the right to the access to health care. It usually occurs due to gaps in public policy or failures in its application. In Brazil, several public institutions have implemented s
Externí odkaz:
https://doaj.org/article/94bf16ec7e73464caaf4bd15ae0b9fff
Publikováno v:
Cadernos de Saúde Pública, Vol 31, Iss 8, Pp 1648-1662 (2015)
O objetivo deste trabalho foi analisar o elenco de medicamentos do Programa Farmácia Popular do Brasil (PFPB) frente à política de assistência farmacêutica vigente no país. O elenco de medicamentos do PFPB foi comparado com listas de referênci
Externí odkaz:
https://doaj.org/article/19df3da698074396954d5163c644f201
Autor:
Sueli Miyuki Yamauti, Jorge Otávio Maia Barreto, Silvio Barberato-Filho, Fernanda Lacerda da Silva Machado, Luciane Cruz Lopes
Publikováno v:
Systematic reviews. 11(1)
Background The judicialization of health care can be understood as a societal response to pressing healthcare needs, which probably are not being adequately addressed by the current healthcare system. This phenomenon increases the strain on service r
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Background The judicialization of health care is a social claim concerning the right to the access to health care. It usually occurs due to gaps in public policy or failures in its application. In Brazil, several public institutions have implemented
Autor:
Thiago Botelho Azeredo, Luciane Cruz Lopes, Brian Godman, Claudia Garcia Serpa Osorio-de-Castro, Vera Lúcia Edais Pepe, Lars L. Gustafsson, Sueli Miyuki Yamauti
Brazil has had a National Essential Medicines List (EML) since 1964. From 2000 to 2010, five consecutive evidence-based editions were produced, building on the essential medicine concept. In 2012, the government changed course to establish a new para
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b645b9f49ec3889d852d500e909de701
https://strathprints.strath.ac.uk/62186/1/Osorio_de_Castro_etal_BCPT_2017_Policy_change_and_the_National_Essential_Medicines_List.pdf
https://strathprints.strath.ac.uk/62186/1/Osorio_de_Castro_etal_BCPT_2017_Policy_change_and_the_National_Essential_Medicines_List.pdf
Autor:
Sueli Miyuki Yamauti, Luciane Cruz Lopes, Silvio Barberato-Filho, José Ruben de Alcântara Bonfim
Publikováno v:
Ciência & Saúde Coletiva, Volume: 22, Issue: 3, Pages: 975-986, Published: MAR 2017
Ciência & Saúde Coletiva v.22 n.3 2017
Ciência & Saúde Coletiva
Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron:ABRASCO
Ciência & Saúde Coletiva, Vol 22, Iss 3, Pp 975-986
Ciência & Saúde Coletiva v.22 n.3 2017
Ciência & Saúde Coletiva
Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron:ABRASCO
Ciência & Saúde Coletiva, Vol 22, Iss 3, Pp 975-986
Resumo A adoção de listas de medicamentos essenciais, compostas por produtos selecionados, é uma das estratégias para seu uso racional. Neste estudo, objetivou-se analisar o elenco de fármacos da Relação Nacional de Medicamentos Essenciais (Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d09e9151b4b1815a9436372be31cbe
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002300975&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002300975&lng=en&tlng=en
Publikováno v:
Cadernos de saude publica. 31(8)
This study aimed to analyze the list of drugs in the Popular Pharmacy Program in Brazil (PFPB) in relation to the country's pharmaceutical care policy. The list of drugs in the PFPB was compared to the Brazilian and international reference lists of e